We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as it was." ...

Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.

CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

That’s how many patients with Covid-19 go on to develop long Covid, according to a study of nearly 458,000 patients at 58 hospitals, published yesterday in JAMA Network Open. It’s about twice the rate ...

President Trump had another medical exam on Tuesday, putting his health under renewed public scrutiny after he has worked to ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Massachusetts Attorney General Andrea Joy Campbell is suing UnitedHealth Group’s insurance subsidiary, UnitedHealthcare, alleging the company intentionally made low-income older adults appear sicker ...

Kuppalli is an infectious diseases physician in Dallas. As the FIFA World Cup approaches, speculation on social media and cable news has already begun: Could Ebola spread at the tournament? The short ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The Trump administration has released a sweeping proposal to overhaul ...

Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.